The optimal cut-off point for differentiating adenocarcinomas with EGFR mutation from adenocarcinomas without EGFR mutation was 34.3%, with values above this threshold being likely to represent adenocarcinomas with EGFR mutation. Here, EGFR is linked to adenocarcinoma.